CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity

Cell Cycle

Volumn 12, Issue 14, 2013, Pages 2210-2218

  Liu, Zhihui ^a   Rader, Julieann ^a   He, Stanley ^a   Phung, Tanya ^a   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CASZ1; Cdk; Cell cycle; Chk1; Cyclin; Neuroblastoma; Rb; Tumor suppressor

Indexed keywords

CASZ1 PROTEIN; CDC25C PROTEIN; CHECKPOINT KINASE 1; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; PROTEIN P21; PROTEIN TYROSINE PHOSPHATASE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; GENE FUNCTION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NEUROBLASTOMA; NEUROBLASTOMA CELL; ONCOGENE MYC; PHASE TRANSITION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; STEADY STATE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 84880410975     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25265     Document Type: Article

References (34)

1. Maris JM. Recent advances in neuroblastoma. N Engl J Med 2010; 362:2202-11; PMID:20558371; http://dx.doi.org/10.1056/NEJMra0804577
2. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3:203-16; PMID:12612655; http://dx.doi.org/10.1038/nrc1014 (Pubitemid 37328872)
3. Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, et al. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 2008; 68:2599-609; PMID:18413728; http://dx.doi.org/10.1158/0008-5472.CAN-07-5032 (Pubitemid 351556258)
4. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001; 15:267-85; PMID:11159908; http://dx.doi.org/10.1101/gad.864201 (Pubitemid 32155143)
5. Carr-Wilkinson J, O'Toole K, Wood KM, Challen CC, Baker AG, Board JR, et al. High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma. Clin Cancer Res 2010; 16:1108-18; PMID:20145180; http://dx.doi.org/10.1158/1078-0432.CCR-09-1865
6. Timofeev O, Cizmecioglu O, Settele F, Kempf T, Hoffmann I. Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J Biol Chem 2010; 285:16978-90; PMID:20360007; http://dx.doi.org/10. 1074/jbc.M109.096552
7. Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci USA 2011; 108:3336-41; PMID:21289283; http://dx.doi.org/10.1073/pnas.1012351108
8. Xu H, Cheung IY, Wei XX, Tran H, Gao X, Cheung NK. Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G(1) checkpoint-defective neuroblastoma. Int J Cancer 2011; 129:1953-62
9. Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim- Stapleton L, et al. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ 2011; 18:1174-83; PMID:21252912; http://dx.doi.org/10.1038/cdd.2010.187
10. Liu Z, Naranjo A, Thiele CJ. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth. PLoS One 2011; 6:e18557; PMID:21490919; http://dx.doi.org/10.1371/ journal.pone.0018557
11. Liu Z, Yang X, Tan F, Cullion K, Thiele CJ. Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation. Biochem Biophys Res Commun 2006; 344:834-44; PMID:16631614; http://dx.doi.org/10.1016/j.bbrc.2006.03.207
12. Henrich KO, Schwab M, Westermann F. 1p36 tumor suppression-a matter of dosage? Cancer Res 2012; 72:6079-88; PMID:23172308; http://dx.doi.org/10.1158/ 0008-5472.CAN-12-2230
13. Schmitz M, Driesch C, Beer-Grondke K, Jansen L, Runnebaum IB, Dürst M. Loss of gene function as a consequence of human papillomavirus DNA integration. Int J Cancer 2012; 131:E593-602; PMID:22262398; http://dx.doi.org/10.1002/ijc.27433
14. Wang C, Liu Z, Woo CW, Li Z, Wang L, Wei JS, et al. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 2012; 72:315-24; PMID:22068036; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0961
15. Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999; 35:531-9; PMID:10492624; http://dx.doi.org/10.1016/S0959-8049(99) 00292-0 (Pubitemid 29192959)
16. Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005; 23:9408-21; PMID:16361640; http://dx.doi.org/10. 1200/JCO.2005.01.5594
17. Senderowicz AM. Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol 2004; 16:670-8; PMID:15530779; http://dx.doi.org/10.1016/j.ceb.2004.09.014 (Pubitemid 39463118)
18. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-8; PMID:7997877; http://dx.doi.org/10.1126/science.7997877
19. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002; 1:103-10; PMID:12429916; http://dx.doi.org/10.4161/cc.1.2.108
20. Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger PP. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle 2010; 9:689-99; PMID:20107323; http://dx.doi.org/10.4161/cc.9.4.10611
21. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65:1053-61; PMID:1828392; http://dx.doi.org/10.1016/0092-8674(91)90557-F (Pubitemid 121001693)
22. Lu Z, Hunter T. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle 2010; 9:2342-52; PMID:20519948; http://dx.doi.org/10.4161/cc.9.12.11988
23. Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 2004; 29:409-17; PMID:15362224; http://dx.doi.org/ 10.1016/j.tibs.2004.06.006 (Pubitemid 39061085)
24. Baldi A, De Luca A, Esposito V, Campioni M, Spugnini EP, Citro G. Tumor suppressors and cell cycle proteins in lung cancer. Patholog Res Int 2011; 2011:605042; PMID:22007345
25. Ho A, Dowdy SF. Regulation of G(1) cell cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev 2002; 12:47-52; PMID:11790554; http://dx.doi.org/10.1016/S0959-437X(01)00263-5 (Pubitemid 34094989)
26. Giordano A, Rustum YM, Wenner CE. Cell cycle: molecular targets for diagnosis and therapy: tumor suppressor genes and cell cycle progression in cancer. J Cell Biochem 1998; 70:1-7; PMID:9632102; http://dx.doi.org/10.1002/ (SICI)1097-4644(19980701)70:13.0.CO;2-T (Pubitemid 28310914)
27. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003; 36:131-49; PMID:12814430; http://dx.doi.org/10.1046/j.1365-2184.2003.00266.x (Pubitemid 36808270)
28. Gaetano C, Matsumoto K, Thiele CJ. In vitro activation of distinct molecular and cellular phenotypes after induction of differentiation in a human neuroblastoma cell line. Cancer Res 1992; 52:4402-7; PMID:1322787
29. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14:1448-59; PMID:10859164 (Pubitemid 30421838)
30. Cui X, Doe CQ. ming is expressed in neuroblast sublineages and regulates gene expression in the Drosophila central nervous system. Development 1992; 116:943-52; PMID:1339340 (Pubitemid 23042435)
31. Mellerick DM, Kassis JA, Zhang SD, Odenwald WF. castor encodes a novel zinc finger protein required for the development of a subset of CNS neurons in Drosophila. Neuron 1992; 9:789-803; PMID:1418995; http://dx.doi.org/10.1016/ 0896-6273(92)90234-5
32. Christine KS, Conlon FL. Vertebrate CASTOR is required for differentiation of cardiac precursor cells at the ventral midline. Dev Cell 2008; 14:616-23; PMID:18410736; http://dx.doi.org/10.1016/j.devcel.2008.01.009 (Pubitemid 351479934)
33. McClellan KA, Slack RS. Novel functions for cell cycle genes in nervous system development. Cell Cycle 2006; 5:1506-13; PMID:16861920; http://dx.doi.org/10.4161/cc.5.14.2980 (Pubitemid 44091969)
34. Fasano CA, Dimos JT, Ivanova NB, Lowry N, Lemischka IR, Temple S. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 2007; 1:87-99; PMID:18371338; http://dx.doi.org/10.1016/j.stem.2007.04.001 (Pubitemid 46865801)